Acta Vet. Brno 2015, 84: 83-89
https://doi.org/10.2754/avb201584020083
Determination of the minimum inhibitory concentration (MIC) and mutant prevention concentration (MPC) of selected antimicrobials in bovine and swine Pasteurella multocida, Escherichia coli, and Staphylococcus aureus isolates
References
1. F, Duran CO, Burch GS 2008 Antimicrobial resistance in swine production. Anim Health Res Rev 9: 135-148
<https://doi.org/10.1017/S1466252308001503>
2. JM 2001: Clinical utility of the new fluoroquinolones for treating respiratory and urinary tract infections. Expert Opin Invest Drugs 10: 213-237
<https://doi.org/10.1517/13543784.10.2.213>
3. JM 2009: New concepts in antimicrobial susceptibility testing: the mutant prevention concentration and mutant selection window approach. Vet Dermatol 20: 383-396
<https://doi.org/10.1111/j.1365-3164.2009.00856.x>
4. JM, Borsos S, Blondeau LD, Blondeau BJJ, Hesje CE 2012: Comparative minimum inhibitory concentrations of enrofloxacin, ceftiofur, florfenicol, tilmikosin and tulathromycin against bovine clinical isolates of Mannheimia haemolytica. Vet Microbiol 160: 85-90
<https://doi.org/10.1016/j.vetmic.2012.05.006>
5. R, Morosini MI 2011: Emergence and spread of antibiotic resistance following exposure to antibiotics. FEMS Microbiol Rev 35: 977-991
<https://doi.org/10.1111/j.1574-6976.2011.00295.x>
6. D, Sun H, Xu J, Gao S 2006: PCR detection of virulence factor genes in Escherichia coli isolates from weaned piglets with oedema disease and/or diarrhoea in China. Vet Microbiol 115: 320-328
<https://doi.org/10.1016/j.vetmic.2006.02.013>
7. CLSI 2013a: Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals; Approved Standard - Fourth Edition. CLSI document Vet 01-A4. Clinical and Laboratory Standards Institute, Wayne, PA 2013
8. CLSI 2013b: Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals; Second Informational Supplement. CLSI document Vet 01-S2. Clinical and Laboratory Standards Institute, Wayne, PA 2013
9. D, Etienne M, Bergoin E, Charles PE, Lequeu C, Piroth L, Portier H, Chavanet P 2004: Mutant selection window in levofloxacin and moxifloxacin treatments of experimental pneumococcal pneumonia in a rabbit model of human therapy. Antimicrob Agents Chemother 48: 1699-1707
<https://doi.org/10.1128/AAC.48.5.1699-1707.2004>
10. K 2001: A strategy for fighting antibiotic resistance. ASM News 67: 27-33
11. EUCAST 2013: Antimicrobial wild type distributions of microorganisms. Version 5.13. [Database online]. European Committee on Antimicrobial Susceptibility Testing. Available at: www.eucast.org. Accessed September 26, 2013
12. KS, Keane SG, Nanijani IA, Benchaoui HA, Sunderland SJ, Jones MA, Weatherley AJ, Gootz TD, Rowan TG 2005: Minimum inhibitory concentrations of tulathromycin against respiratory bacterial pathogens isolated from clinical cases in European cattle and swine and variability arising from changes in in vitro methodology. Vet Ther 6: 113-121
13. C, Tillotson GS, Blondeau JM 2007: MICs, MPCs and PK/PDs: a match (sometimes) made in hosts. Expert Rev Resp Med 1: 7-16
<https://doi.org/10.1586/17476348.1.1.7>
14. Lees P, Svendsen O, Wiuff C 2008: Chapter 6. Strategies to minimise the impact of antimicrobial treatment on the selection of resistant bacteria. In: Guardabassi L (Ed): Guide to Antimicrobial Use in Animals 2008. Blackwell Publishing, Oxford, pp 77-101
15. MA, Inskeep PB, Risk JE, Skogerboe TL, Benchaoui HA, Meinert TR, Sherington J, Sunderland SJ 2004: Pharmacokinetics and lung tissue cocentrations of tulathromycin, a new triamilide antibiotic, in cattle. Vet Ther 5: 60-74
16. L, Cooles S, Piddock L, Woodward M 2004: Mutant prevention concentrations of ciprofloxacin and enrofloxacin for Salmonella enterica. J Antimicrob Chemother 54: 688-691
<https://doi.org/10.1093/jac/dkh360>
17. VH, Louie A, Deziel MR, Liu W, Leary R, Drusano GL 2005: Bacterial-population responses to drug-selective pressure: examination of garenoxacin’s effect on Pseudomonas aeruginosa. J Infect Dis 192: 420-428
<https://doi.org/10.1086/430611>
18. KM, Frost AJ, Lee CW, Papadimitriou JM, Dawkins HJS 1998: Development of PCR assays for species and type specific identification of Pasteurella multocida isolates. J Clin Microbiol 36: 1096-1100
<https://doi.org/10.1128/JCM.36.4.1096-1100.1998>
19. J 2006: Monitoring of antimicrobial resistance in pathogenic bacteria from livestock animals. Int J Med Microbiol 296: 81-86
<https://doi.org/10.1016/j.ijmm.2006.01.064>
20. X, Drlica K 2008: A unified anti-mutant dosing strategy. J Antimicrob Chemother 62: 434-436
<https://doi.org/10.1093/jac/dkn229>
